Strategic partnerships GSK is actively expanding international presence and investing in asset acquisitions in the oncology space, particularly trispecific T-cell engager therapies. This suggests opportunities to engage on collaborative research support, clinical data management, and regional regulatory affairs services to align with their fast-evolving pipeline.

Tech-enabled expansion The company is deploying advanced workplace and collaboration technologies for a new 13-floor London HQ, indicating a need for integrated AV, structured cabling, smart building solutions, and IT services that scale across large facilities both domestically and in Europe.

Vaccine portfolio shift Recent notes indicate waning demand for traditional flu vaccines, signaling potential for clinical data analytics, demand forecasting, and supply chain optimization services to support pivot strategies and more resilient vaccine production and distribution.

Global rights deals GSK is securing global rights to novel T-cell engager assets with major Asia-based developers, highlighting a potential need for global commercialization planning, market access strategy, and regional clinical operations support to maximize new asset value.

Marketing and branding Award-winning marketing campaigns and high-profile sponsorships imply continued investment in external communications, patient engagement, and digital marketing services, offering opportunities for creative, analytics-driven marketing partnerships and channel optimization.